ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule

RxCUI: 2641601
RxNorm name: ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule
Display name: ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule
Full name: ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:02

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Litfulo	RITLECITINIB	U.S. Pharmaceuticals	1882f799-61b0-4813-965a-4910c4ae419c	2026-06-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641601
Litfulo	RITLECITINIB	Pfizer Laboratories Div Pfizer Inc	6b2f9446-fb23-4741-b73a-5a2f993733c3	2026-06-17	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641601

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
6b2f9446-fb23-4741-b73a-5a2f993733c3	ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule	SY	5	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20260527
6b2f9446-fb23-4741-b73a-5a2f993733c3	ritlecitinib 50 MG Oral Capsule	PSN	5	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20260527
6b2f9446-fb23-4741-b73a-5a2f993733c3	ritlecitinib 50 MG Oral Capsule	SCD	5	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20260527
1882f799-61b0-4813-965a-4910c4ae419c	ritlecitinib 50 MG Oral Capsule	PSN	2	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20250320
1882f799-61b0-4813-965a-4910c4ae419c	ritlecitinib 50 MG (equivalent to ritlecitinib tosylate 80.13 MG) Oral Capsule	SY	2	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20250320
1882f799-61b0-4813-965a-4910c4ae419c	ritlecitinib 50 MG Oral Capsule	SCD	2	These highlights do not include all the information needed to use LITFULO safely and effectively. See full prescribing information for LITFULO. LITFULO™ (ritlecitinib) capsules, for oral use Initial U.S. Approval: 2023	20250320